Related Experiment Video
Updated: Dec 18, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Advances in the discovery of exosome inhibitors in cancer
Huarui Zhang1,2, Jun Lu1,3,2, Jin Liu1,2
1Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases (TMBJ), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Abstract:
Exosomes are small membrane vesicles released by most eukaryotic cells. They are considered to play an essential role in cell-to-cell communication, and It is also found that they serve as functional mediators in many severe diseases, including progression of various types of cancers. Inhibition of exosome release may slow the progression of some cancers; thus, exosome has been an attractive target for cancer treatment. Over the years, considerable efforts have been made to discover novel, highly potent and excellently selective exosome inhibitors. Most of these inhibitors are derived from synthetic compounds, some of which are currently existed drugs and found to have the potential to inhibit exosome release. In this review, we briefly discussed the development of exosome inhibitors that are currently discovered and provided guidance for the future development of inhibitors.
Insights
Exosomes are key in cell communication and cancer progression. Inhibiting exosome release offers a promising cancer treatment strategy, with ongoing research into novel exosome inhibitors.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Exosomes are vital vesicles mediating cell-to-cell communication.
- Exosomes play a significant role in the progression of various cancers.
- Targeting exosome release presents a potential therapeutic strategy for cancer treatment.
Purpose of the Study:
- To review the development of exosome inhibitors.
- To discuss currently discovered exosome inhibitors.
- To provide guidance for future inhibitor development.
Main Methods:
- Literature review of exosome inhibitor research.
- Analysis of synthetic compounds and existing drugs with inhibitory potential.
- Discussion of exosome inhibitor discovery and development.
Main Results:
- Exosome inhibitors are primarily derived from synthetic compounds.
- Some existing drugs demonstrate potential in inhibiting exosome release.
- Significant efforts are directed towards discovering potent and selective exosome inhibitors.
Conclusions:
- Exosome inhibition is a promising avenue for cancer therapy.
- Further research is needed to develop novel and effective exosome inhibitors.
- Understanding exosome biology is crucial for advancing cancer treatment strategies.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...

